Adenosine-stimulated atrial natriuretic peptide release through A 1 receptor subtype

Hypertension

Volumn 46, Issue 6, 2005, Pages 1381-1387

  Yuan, Kuichang ^a   Cao, Chunhua ^a   Jeong, Hee Han ^a   Sung, Zoo Kim ^a   Suhn, Hee Kim ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Adenosine; Cyclin AMP; Heart; Hypertension, experimental; Kidney; Natriuretic peptides; Receptor

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N CYCLOPENTYLADENOSINE; 8 BROMO CYCLIC AMP; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; FORSKOLIN; ISOPRENALINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ATRIUM; HEART PERFUSION; HEMODYNAMICS; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

EID: 31944450620     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000190041.61737.fd     Document Type: Article

References (24)

1. Sparks HV Jr, Bardenheuer H. Regulation of adenosine formation by the heart. Circ Res. 1986;58:193-201.
2. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol. 1995;35:581-606.
3. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
4. Auchampach JA, Bolli R. Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges. Am J Physiol. 1999;276:H1113-H1116.
5. Srinivas M, Song Y, Shryock JC, Belardinelli L. Cardiac electrophysiological actions of adenosine. Drug Dev Res. 1998;45:420-426.
6. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation. 1992;85:893-904.
7. Nakano A, Cohen MV, Downey JM. Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther. 2000;86:263-275.
8. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci. 1994;15:298-306.
9. Elias AN, Wesley RC, Gordon IL, Pandian MR, Vaziri ND. Effects of adenosine infusion on renal function, plasma ANP and ADH concentrations and central hemodynamics in anesthetized pigs. Gen Pharmacol. 1997;28:429-433.
10. Sala C, Monopoll A, Alberti C, Casati C, Ongini E, Zanchetti A, Morganti A. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. J Hypertens. 1996;14:75-79.
11. Salman H, Bergman M, Schlesinger H, Zahavi I, Kessler-Icekson G. Adenosine stimulates ANP expression in cultured ventricular cardiomyocytes. J Cardiovasc Phannacol. 1999;34:7-9.
12. Uusimaa PA, Kiviluoma KT, Toth M, Hassinen IE, Peuhkurinen KJ, Ruskoaho H. Adenosine inhibits the release of atrial natriuretic peptide from the perfused rat heart. Eur J Pharmacol 1993;242:199-203.
13. Han JH, Cao C, Kim SC, Cho KW, Kim SH. Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C. Hypertension. 2003;41:1380-1385.
14. Cho KW, Seul KH, Kim SH, Koh GY, Seul KM, Hwang YH. Sequential mechanism of atrial natriuretic peptide secretion in isolated perfused rabbit atria. Biochem Biophys Res Commun. 1990;172:423-431.
15. Cho KW, Seul KH, Ryu H, Kim SH, Koh GY. Characteristics of distension-induced release of immunoreactive atrial natriuretic peptide in isolated perfused rabbit atria. Regul Peptides. 1988;22:333-345.
16. Cho KW, Kim SH, Hwang YH, Seul KH. Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion. J Physiol. 1993;468:591-607.
17. Cui X, Lee SJ, Kim SZ, Kim SH, Cho KW. Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria. Eur J Pharmacol. 2000;402:129-137.
18. Cao C, Piao FL, Han JH, Kim SZ, Kim SH. ATP-stimulated ANP release through P1 receptor subtype. Regul Peptides. 2005;127:37-43.
19. (2+)-independent cAMP inhibition of ANP release in beating rabbit atria. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1477-R1489.
20. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res. 1999;84:1396-1400.
21. Louttit JB, Hunt AA, Maxwell MP, Drew GM. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischemia-reperfusion injury in the pig. J Cardiovasc Pharmacol. 1999;33:285-291.
22. Miura T, Tsuchida A. Adenosine and preconditioning revisited. Clin Exp Pharmacol Physiol. 1999;26:92-99.
23. 1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A. 1997;94:6541-6546.
24. 1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res. 2003;93:759-766.